BATS:ARKG

Ark Genomic Revolution Etf ETF Forecast

etoro logo Buy ARKG
*Your capital is at risk
$41.43
+1.32 (+3.29%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of ARKG AI-Powered Market Insights
ETF Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ARKG to Watchlist?
  • Easy Tracking In The Watchlist
PDF

ARK Genomic Revolution ETF downgraded from Strong Buy Candidate to Hold/Accumulate after Friday trading session
(Updated on Jun 26, 2026)

Buy or Hold candidate since May 21, 2026 Gain 35.70%

The ARK Genomic Revolution ETF price gained 3.29% on the last trading day (Friday, 26th Jun 2026), rising from $40.11 to $41.43. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 5.85% from a day low at $39.82 to a day high of $42.15. The price has risen in 6 of the last 10 days and is up by 23.12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $277.04 million.

The ETF has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $39.13, a level that may pose a second chance to hit a runner. According to fan-theory $45.61 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ARKG Signals & Forecast

The ARK Genomic Revolution ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $37.78 and $33.14. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 26.12%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ARK Genomic Revolution ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $38.58 and $36.86. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, ARK Genomic Revolution finds support just below today's level at $38.58. If this is broken, then the next support from accumulated volume will be at $36.86 and $36.27.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $2.33 between high and low, or 5.85%. For the last week, the ETF has had daily average volatility of 4.95%.

The ARK Genomic Revolution ETF is extremely overbought on RSI14 (82). Normally this may pose a good selling opportunity but since the ETF has broken the trend up, the chance for a major correction due to high RSI is very small as the ETF will find support at the trend broken.

Our recommended stop-loss: $40.04 (-3.36%) (This ETF has medium daily movements and this gives medium risk. The RSI14 is 82 and this increases the risk substantially. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (ARKG) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect ARK Genomic Revolution ETF to open at $41.13, and during the day (based on 14 day Average True Range), to move between $40.57 and $42.29, which gives a possible trading interval of +/-$1.73 (+/-4.25%) up or down from last closing price. If ARK Genomic Revolution ETF takes out the full calculated possible swing range there will be an estimated 4.25% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $38.58, some $2.85 (6.88%) from the current price of $41.43, our system finds the risk reward attractive.

Is ARK Genomic Revolution ETF ETF A Buy?

ARK Genomic Revolution holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $41.13 ( 0.717%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ARKG Performance

Trading levels for ARKG

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 43.46 4.90%
R2 42.57 2.76%
R1 42.02 1.43%
Price 41.43
S1 40.24 -2.86%
S2 39.69 -4.19%
S3 38.80 -6.34%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 41.43
S1 38.58 -6.88%
S2 36.86 -11.03%
S3 36.27 -12.45%

ARKG Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 29, 2021 Dec 29, 2021 Dec 29, 2021 $0.382 0.636%
2 Dec 29, 2020 Dec 29, 2020 Dec 29, 2020 $0.790 0.84%
3 Dec 26, 2019 Dec 27, 2019 Dec 31, 2019 $1.05 3.14%
4 Dec 26, 2018 Dec 27, 2018 Dec 31, 2018 $0.466 1.94%
5 Dec 26, 2017 Dec 27, 2017 Dec 29, 2017 $0.328 1.34%

FAQ

What is the symbol for ARK Genomic Revolution ETF ETF and on which exchange is it traded?
The symbol for ARK Genomic Revolution ETF is ARKG and it is traded on the BATS (BATS Global Markets).

Should I buy or sell ARK Genomic Revolution ETF ETF?
ARK Genomic Revolution holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Hold candidate.

How to buy ARK Genomic Revolution ETF ETF?
ARK Genomic Revolution ETF ETF can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ARK Genomic Revolution ETF ETF.

What's the current price of ARK Genomic Revolution ETF ETF?
As of the end of day on the Jun 26, 2026, the price of an ARK Genomic Revolution ETF (ARKG) share was $41.43.

What is the 52-week high and low for ARK Genomic Revolution ETF ETF?
The 52-week high for ARK Genomic Revolution ETF ETF is $42.15 and the 52-week low is $22.73.

What is the market capitalization of ARK Genomic Revolution ETF ETF?
As of the Jun 26, 2026, the market capitalization of ARK Genomic Revolution ETF is 1.502B.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE